Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph- B-Lineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 Trial

Blood (2023) 142 (Supplement 1): 826.

https://doi.org/10.1182/blood-2023-174973

Published: 2023

Journal Articles

A New Gene Expression Profile Signature CRLF2 Overexpression Based Identifies Novel Adult "Triple Negative" Acute Lymphoblastic Leukemia Subgroups

Blood (2018) 132 (Supplement 1): 5284.

https://doi.org/10.1182/blood-2018-99-118062

Published: 2018

Journal Articles

Comparative Analysis between RQ-PCR, Digital-Droplet-PCR and Next-Generation-Sequencing (NGS) of Immunoglobulin/T-Cell Receptor Gene Rearrangements to Monitor Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia Patients

Irene Della Starza, PhD, Lucia Anna De Novi, PhD, Alessandra Santoro, PhD, Salemi Domenico, PhD, Marzia Cavalli, PhD, Roberta Soscia, Francesca Paoloni, Lucia Menale, Valerio Apicella, Caterina Ilari, PhD, Antonella Vitale, Marco Vignetti, MD, Renato Bassan, MD, Sabina Chiaretti, MD PhD, Anna Guarini, PhD, Robin Foà, MD

Blood (2018) 132 (Supplement 1): 2828.

https://doi.org/10.1182/blood-2018-99-118219

Published: 2018

Journal Articles

Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience

Blood (2016) 128 (22): 5191.

https://doi.org/10.1182/blood.V128.22.5191.5191

Published: 2016

Journal Articles

Clustering Adult ACUTE Lymphoblastic Leukemia (ALL) Philadelphia Negative (Ph-) By Whole Exome Sequencing (WES) Analysis

Blood (2015) 126 (23): 2623.

https://doi.org/10.1182/blood.V126.23.2623.2623

Published: 2015

Journal Articles

Successful Salvage Treatment With Clofarabine and Cytarabine In Relapsed/Refractory Acute Myeloid Leukemia

Alessandra Malato, MD, PhD, Francesco Acquaviva, Alessandra Santoro, PhD, Rosaria Felice, MD, Silvana Magrin, MD, Diamante Turri, MD, Rosanna Scimè, MD, Raimondo Di Bella, MD, Domenico Salemi, Francesco Fabbiano, MD

Blood (2013) 122 (21): 5039.

https://doi.org/10.1182/blood.V122.21.5039.5039

Published: 2013

Journal Articles

Distinctive Patterns of Intraclonal Diversification In IGHV1-2*04 Immunoglobulin Receptors of Patients with Splenic Marginal Zone Lymphoma: A of Ongoing Interactions with Antigen?

Blood (2011) 118 (21): 2638.

https://doi.org/10.1182/blood.V118.21.2638.2638

Published: 2011

Journal Articles

Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis

Blood (2011) 117 (25): 6793–6800.

https://doi.org/10.1182/blood-2011-01-328294

Published: 2011

Includes: Supplemental data

Journal Articles

Over 30% of Patients with Splenic Marginal Zone Lymphoma Express Distinctive Antigen Receptors Utilizing a Single Immunoglogulin Variable Gene: Implications for the Origin and Selection of the Neoplastic Cells

Blood (2010) 116 (21): 634.

https://doi.org/10.1182/blood.V116.21.634.634

Published: 2010

Journal Articles

Altered mRNA Expression of Pax-5 Is a Common Event in Acute Lymphoblastic Leukemia.

Alessandra Santoro, Lea Dagnino, Cecilia Agueli, Domenico Salemi, Maria Grazia Bica, Annalisa Marfia, Sonia Cannella, Marinella Veltroni, Valentina Cetica, Emanuela Giarin, Francesco Fabbiano, MD, Giuseppe Basso, MD, Maurizio Arico, MD

Blood (2008) 112 (11): 1189.

https://doi.org/10.1182/blood.V112.11.1189.1189

Published: 2008

Journal Articles

Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia

Dragana Jankovic, Paolo Gorello, Ting Liu, Sabire Ehret, Roberta La Starza, Cecile Desjobert, Florent Baty, Martin Brutsche, Padma-Sheila Jayaraman, Alessandra Santoro, Christina Mecucci, Juerg Schwaller

Blood (2008) 111 (12): 5672–5682.

https://doi.org/10.1182/blood-2007-09-108175

Published: 2008

Includes: Supplemental data

Journal Articles

Defective CD107a Surface Expression Heralds Munc13-4 Defect and Discriminates between Genetic Subtypes of Familial Hemophagocytic Lymphohistiocytosis (FHL).

Maurizio Aricò, Stefania Marcenaro, Federico Gallo, Stefania Martini, Alessandra Santoro, Gillian M. Griffiths, Lorenzo Moretta, Daniela Pende

Blood (2006) 108 (11): 1248.

https://doi.org/10.1182/blood.V108.11.1248.1248

Published: 2006

Journal Articles

MUNC13–4 Mutations in Patients with Hemophagocytic Lymphohistiocytosis Are Scattered over the Functional Domains of the Protein.

Alessandra Santoro, Sonia Cannella, Giovanna Bossi, Federico Gallo, Antonino Trizzino, Daniela Pende, Francesco Dieli, Giuseppa Bruno, Jane C. Stinchcombe, Caterina Putti, Carmela De Fusco, Cesare Danesino, Lorenzo Moretta, Luigi D. Notarangelo, Gillian Griffiths, Maurizio Aricò

Blood (2006) 108 (11): 1249.

https://doi.org/10.1182/blood.V108.11.1249.1249

Published: 2006

Journal Articles

Analysis of natural killer–cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease

Stefania Marcenaro, Federico Gallo, Stefania Martini, Alessandra Santoro, Gillian M. Griffiths, Maurizio Aricó, Lorenzo Moretta, Daniela Pende

Blood (2006) 108 (7): 2316–2323.

https://doi.org/10.1182/blood-2006-04-015693

Published: 2006

Journal Articles

Novel Munc13-4 Mutations in Patients with Hemophagocytic Lymphohistiocytosis.

Alessandra Santoro, Sonia Cannella, Antonino Trizzino, Cesare Danesino, Daniela Pende, Carmen De Fusco, Concetta Micalizzi, Patrizia Bertolini, Lorenzo Moretta, Luigi D. Notarangelo, Gillian M. Griffiths, Maurizio Aricò

Blood (2005) 106 (11): 2807.

https://doi.org/10.1182/blood.V106.11.2807.2807

Published: 2005

Journal Articles

A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin

Christina Trambas, Federico Gallo, Daniela Pende, Stefania Marcenaro, Lorenzo Moretta, Carmela De Fusco, Alessandra Santoro, Luigi Notarangelo, Maurizio Arico, Gillian M. Griffiths

Blood (2005) 106 (3): 932–937.

https://doi.org/10.1182/blood-2004-09-3713

Published: 2005

Journal Articles

Molecular Remission Can Be Attained in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphomas after Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLO-SCT).

Lucia Farina, MD, Matteo Carrabba, MD, Anna Dodero, MD, Elena Rizzo, BS, Elisabetta Zorzan, BS, Fabio Ciceri, MD, Anna Locasciulli, MD, Attilio Olivieri, MD, Alessandro Rambaldi, MD, Corrado Tarella, MD, Alessandra Santoro, MD, Francesca Patriarca, MD, Andrea Bacigalupo, MD, Paolo Corradini, MD

Blood (2004) 104 (11): 2317.

https://doi.org/10.1182/blood.V104.11.2317.2317

Published: 2004

Journal Articles

Early Detection of Relapse by Prospective Reverse Transcriptase-Polymerase Chain Reaction Analysis of the PML/RARα Fusion Gene in Patients With Acute Promyelocytic Leukemia Enrolled in the GIMEMA-AIEOP Multicenter “AIDA” Trial

Daniela Diverio, Vincenzo Rossi, Giuseppe Avvisati, Silvia DeSantis, Alessandra Pistilli, Fabrizio Pane, Giuseppe Saglio, Giovanni Martinelli, Maria Concetta Petti, Alessandra Santoro, Pier Giuseppe Pelicci, Franco Mandelli, Andrea Biondi, Francesco Lo Coco

Blood (1998) 92 (3): 784–789.

https://doi.org/10.1182/blood.V92.3.784

Published: 1998

NARROW

Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph- B-Lineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 Trial

A New Gene Expression Profile Signature CRLF2 Overexpression Based Identifies Novel Adult "Triple Negative" Acute Lymphoblastic Leukemia Subgroups

Comparative Analysis between RQ-PCR, Digital-Droplet-PCR and Next-Generation-Sequencing (NGS) of Immunoglobulin/T-Cell Receptor Gene Rearrangements to Monitor Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia Patients

Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience

Clustering Adult ACUTE Lymphoblastic Leukemia (ALL) Philadelphia Negative (Ph-) By Whole Exome Sequencing (WES) Analysis

Successful Salvage Treatment With Clofarabine and Cytarabine In Relapsed/Refractory Acute Myeloid Leukemia

Distinctive Patterns of Intraclonal Diversification In IGHV1-2*04 Immunoglobulin Receptors of Patients with Splenic Marginal Zone Lymphoma: A of Ongoing Interactions with Antigen?

Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis

Over 30% of Patients with Splenic Marginal Zone Lymphoma Express Distinctive Antigen Receptors Utilizing a Single Immunoglogulin Variable Gene: Implications for the Origin and Selection of the Neoplastic Cells

Altered mRNA Expression of Pax-5 Is a Common Event in Acute Lymphoblastic Leukemia.

Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia

Defective CD107a Surface Expression Heralds Munc13-4 Defect and Discriminates between Genetic Subtypes of Familial Hemophagocytic Lymphohistiocytosis (FHL).

MUNC13–4 Mutations in Patients with Hemophagocytic Lymphohistiocytosis Are Scattered over the Functional Domains of the Protein.

Analysis of natural killer–cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease

Novel Munc13-4 Mutations in Patients with Hemophagocytic Lymphohistiocytosis.

A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin

Molecular Remission Can Be Attained in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphomas after Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLO-SCT).

Early Detection of Relapse by Prospective Reverse Transcriptase-Polymerase Chain Reaction Analysis of the PML/RARα Fusion Gene in Patients With Acute Promyelocytic Leukemia Enrolled in the GIMEMA-AIEOP Multicenter “AIDA” Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only